Union Korea Pharm Income Statement

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Revenue	36,378	51,280	63,169	61,293	48,304
Other Revenue	-0	-	-0	-	-
Revenue	36,378	51,280	63,169	61,293	48,304
Revenue Growth (YoY)	-29.06%	-18.82%	3.06%	26.89%	-4.12%
Cost of Revenue	28,619	37,156	42,388	37,377	33,154
Gross Profit	7,759	14,124	20,781	23,917	15,150
Selling, General & Admin	15,801	27,632	24,675	22,147	23,987
Research & Development	812.4	1,027	833.33	922.15	2,451
Amortization of Goodwill & Intangibles	55	301.46	311.24	350.72	368.82
Other Operating Expenses	232.79	264.02	244.29	294.22	196.45
Operating Expenses	31,085	32,778	35,463	22,646	25,764
Operating Income	-23,326	-18,654	-14,682	1,271	-10,615
Interest Expense	-3,243	-3,920	-4,112	-2,843	-2,229
Interest & Investment Income	27.29	97.74	105.43	47.61	46.64
Earnings From Equity Investments	-518.08	-23.89	-19.46	-5.47	-9.49
Currency Exchange Gain (Loss)	-24.04	89.97	9.98	-55.14	96.43
Other Non Operating Income (Expenses)	-259.36	7,264	1,695	2,528	-1,628
EBT Excluding Unusual Items	-27,343	-15,146	-17,004	943.54	-14,338
Gain (Loss) on Sale of Assets	35.25	0.67	129.04	-	7.54
Asset Writedown	-	-	-	-	-146.73
Other Unusual Items	-498.94	-3,826	2,471	-	-
Pretax Income	-27,806	-18,972	-14,404	943.54	-14,477
Income Tax Expense	3,014	1,944	3,753	1,876	-3,367
Net Income	-30,820	-20,916	-18,156	-932.02	-11,109
Net Income to Common	-30,820	-20,916	-18,156	-932.02	-11,109
Shares Outstanding (Basic)	7	7	7	7	8
Shares Outstanding (Diluted)	7	7	7	7	8
Shares Change (YoY)	0.03%	0.09%	-2.14%	-5.05%	16.95%
EPS (Basic)	-4263.00	-2894.00	-2514.45	-126.31	-1429.59
EPS (Diluted)	-4263.00	-2894.00	-2514.45	-126.31	-1430.00
Free Cash Flow	-1,230	-529.23	-901.15	-8,429	-5,254
Free Cash Flow Per Share	-170.11	-73.22	-124.80	-1142.33	-676.09
Gross Margin	21.33%	27.54%	32.90%	39.02%	31.36%
Operating Margin	-64.12%	-36.38%	-23.24%	2.07%	-21.98%
Profit Margin	-84.72%	-40.79%	-28.74%	-1.52%	-23.00%
Free Cash Flow Margin	-3.38%	-1.03%	-1.43%	-13.75%	-10.88%
EBITDA	-21,523	-15,777	-10,792	5,266	-6,389
EBITDA Margin	-59.16%	-30.77%	-17.08%	8.59%	-13.23%
D&A For EBITDA	1,803	2,877	3,890	3,994	4,226
EBIT	-23,326	-18,654	-14,682	1,271	-10,615
EBIT Margin	-64.12%	-36.38%	-23.24%	2.07%	-21.98%
Effective Tax Rate	-	-	-	198.78%	-
Advertising Expenses	5.29	302.81	1,984	865.84	1,090

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.